Sigma Planning Corp Has $254,000 Stock Holdings in Teladoc Health Inc (NYSE:TDOC)

Sigma Planning Corp boosted its position in Teladoc Health Inc (NYSE:TDOC) by 9.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,753 shares of the health services provider’s stock after acquiring an additional 330 shares during the period. Sigma Planning Corp’s holdings in Teladoc Health were worth $254,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. CENTRAL TRUST Co lifted its holdings in shares of Teladoc Health by 82.6% in the second quarter. CENTRAL TRUST Co now owns 378 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 171 shares in the last quarter. Meridian Wealth Management LLC bought a new position in shares of Teladoc Health in the second quarter valued at approximately $27,000. Westside Investment Management Inc. bought a new position in shares of Teladoc Health in the second quarter valued at approximately $26,000. Capital Investment Advisory Services LLC lifted its holdings in shares of Teladoc Health by 800.0% in the third quarter. Capital Investment Advisory Services LLC now owns 450 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 400 shares in the last quarter. Finally, Cornerstone Advisors Inc. lifted its holdings in shares of Teladoc Health by 187.0% in the second quarter. Cornerstone Advisors Inc. now owns 465 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 303 shares in the last quarter.

A number of research analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their target price on Teladoc Health from $82.00 to $83.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. SunTrust Banks raised their target price on Teladoc Health to $80.00 and gave the company a “positive” rating in a report on Tuesday, August 6th. Credit Suisse Group raised their target price on Teladoc Health from $67.00 to $76.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Oppenheimer set a $83.00 price target on Teladoc Health and gave the company a “buy” rating in a research report on Friday, September 6th. Finally, Svb Leerink reaffirmed an “outperform” rating on shares of Teladoc Health in a research report on Thursday, August 1st. Three research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $77.43.

In other news, insider Adam C. Vandervoort sold 50,955 shares of Teladoc Health stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $75.00, for a total value of $3,821,625.00. Following the completion of the transaction, the insider now directly owns 9,769 shares in the company, valued at $732,675. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Gabriel R. Cappucci sold 9,569 shares of Teladoc Health stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $75.00, for a total value of $717,675.00. Following the completion of the transaction, the chief accounting officer now owns 10,798 shares of the company’s stock, valued at $809,850. The disclosure for this sale can be found here. Insiders sold 73,057 shares of company stock valued at $5,336,085 over the last three months. Company insiders own 3.14% of the company’s stock.

Shares of TDOC traded down $0.13 on Tuesday, reaching $80.87. 28,751 shares of the company’s stock traded hands, compared to its average volume of 1,311,695. The company has a current ratio of 6.55, a quick ratio of 6.55 and a debt-to-equity ratio of 0.44. The stock has a market cap of $5.92 billion, a PE ratio of -56.23 and a beta of 1.39. The stock’s 50 day simple moving average is $70.82 and its two-hundred day simple moving average is $64.82. Teladoc Health Inc has a 52-week low of $42.08 and a 52-week high of $82.86.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.40) by $0.12. Teladoc Health had a negative return on equity of 11.23% and a negative net margin of 20.15%. The business had revenue of $137.96 million during the quarter, compared to the consensus estimate of $136.46 million. During the same period last year, the business posted ($0.34) earnings per share. The business’s revenue for the quarter was up 24.3% on a year-over-year basis. Analysts forecast that Teladoc Health Inc will post -1.43 earnings per share for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: What is the yield curve?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.